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Summary 
Major histocompatibility complex (MHC) class I molecules are cell-surface proteins that present 
peptides to CD8 + T  cells.  These peptides are mostly derived from endogenously synthesized 
protein.  Recombinant,  soluble MHC class  I  molecules were produced,  purified,  and loaded 
homogeneously with synthetic peptide. These MHC-peptide complexes were used to activate 
a T  cell hybridoma.  While monomers of MHC-peptide bound to the T  cell,  they showed no 
stimulatory activity. Dimers fully triggered the T cell hybridoma to secrete interleukin 2. This 
response was followed by a state in which the T  cell was refractory to restimulation  as a result 
of defective signal  transduction  through  the T  cell receptor. 
T  lymphocytes recognize through TCR a molecular com- 
plex consisting of an antigenic peptide bound to an MHC- 
encoded molecule on the surface of APC (1). In developing 
thymocytes, TCR engagement can either induce cell death 
or rescue from a programmed cell death (2). Tolerance to self 
and self-MHC restriction are thought to be in large part the 
result of these interactions  through  processes referred to as 
thymic selection and education. In mature T cells, TCR en- 
gagement can either induce clonal expansion and differentia- 
tion or lead to a long-lived state of unresponsiveness called 
anergy (3).  In Thl CD4 + cells, antigen receptor occupancy 
(signal 1) in conjunction with a second costimulatory signal 
synergizes to produce IL-2 and leads to T cell activation (4). 
In the same cells, TCR engagement alone in the absence of 
costimulation leads to anergy or deletion. Less is known about 
CD8 + T  cells.  In  a few instances,  anergy can be induced 
using fixed APC or immobilized anti-TCR mAb, but such 
anergized CD8 § T cells maintained CTL killing activity (5, 
6). Anergy has been proposed to explain the immune toler- 
ance to self-antigens not presented in the thymus by a pro- 
cess referred  to as peripheral  tolerance (7). 
In vitro models have been developed that have allowed the 
identification of some of the surface molecules through which 
the costimulatory signals (signal 2) are delivered.  A domi- 
nant role has been demonstrated in mouse CD4 + T cells for 
CD28 (8). Coexpression on the same APC of the B7 mole- 
cule (the ligand of CD28) and a specific MHC-peptide com- 
plex allows the induction of CD8 + CTL (9).  Other cell sur- 
face molecules like CD2, leukocyte function-associated anti- 
gen-1, or very late antigen-4 have also been implicated (10). 
After antigenic stimulation,  T  hybridoma cells become un- 
responsive to restimulation  (11, 12). This state,  which lasts 
for 2 to 3 wk, resembles anergy as defined by functional in- 
activation  and failure to produce IL-2 (13). 
The ability to produce recombinant MHC molecules and 
to load them with exogenous peptides provides a more quan- 
titative approach to addressing this issue and studying T cell 
triggering.  We have previously constructed a single-chain, 
soluble  MHC  class  I  H-2K  a  molecule  (SC-Ka) 1 by con- 
necting the COOH terminus  of the ectodomain of the na- 
tive H-2K  d molecule to  the  NH2  terminus  of the  mouse 
B2-microglobulin through a 15-amino acid-long spacer (14). 
Unlike native MHC molecules purified from cells, this recom- 
binant  molecule is soluble in the absence of detergent  and 
is homogeneous with respect to the ~2-microglobulin,  con- 
taining only B2-microglobulin of mouse origin.  It was pro- 
duced in large quantities using baculo virus-infected insect 
cells, yeast, or Chinese hamster ovary cells and was shown 
to bind synthetic peptides with  the same specificity as the 
native,  cell surface-associated H-2K  a (15-17). 
In the present  study, we show that  recombinant  single- 
chain SC-K  a molecule loaded with  an antigenic  peptide is 
i Abbreviations used in this paper: PKC, protein kinase C; SC-Ka, single- 
chain soluble MHC class I H-2K  d molecule. 
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cell hybridoma or a basophilic cell transfected with the TCR 
fused to CD3-~'.  Cell activation requires  at least dimeriza- 
tion of the MHC molecules. In T hybridoma cells, as it has 
been shown using antigen-bearing APC (11, 12), this activa- 
tion is followed by a state of unresponsiveness,  which results 
from a block in signal transduction through the TCR. 
Materials and Methods 
Peptides.  The Cw3 (RYLKNGKETL), NP (TYQRTRALV), 
and PbCS (YIPSAEKI) peptides have  been previously  described  (18) 
and were obtained after HPLC purification from Neosystem SA 
(Strasbourg, France). 
mAbs.  The SF1-1.1.1 mAb (HB158; American Type Culture 
Collection, Rockville, MD) is specific for the ~3 domain of K  a 
(17). The 20-8-4S recognizes an epitope in the c~1-c~2 domains of 
K  d or K  b (19). These two mAb were purified on protein A-Sepha- 
rose (Pharmacia LKB Biotechnology, Inc., Piscataway, NJ) as de- 
scribed (20). The H57-597, which recognizes the C/3 domain of 
the TCR (21), was purchased from Pharmingen (San Diego, CA). 
The F23.1 mAb (22), which recognizes a determinant on VB8 + 
TCR, was generously provided by P. Marche (Pasteur Institute, 
Paris, France). Fab and F(ab')2 fragments were prepared as de- 
scribed (20). 
Preparation of Soluble K d.  The SC-K  d sequence (14) was cloned 
into the amplifiable  expression vector pFKSV (23) and transfected 
into Chinese hamster  ovary cells. Clones resistant to 0.5  /tM 
methotrexate were selected and subjected to stepwise increases in 
methotrexate concentration from 1 to 500/~M, Secreted K  a was 
monitored in the culture supernatant by ELISA in microtitration 
plates coated with SF1-1.1.1 and revealed  using biotinylated 20-8-4S 
and horseradish peroxidase-labeled streptavidin (Sigma Chemical 
Co., St. Louis, MO). High-producer transfectant clones were cul- 
tivated in roller bottle in ct-MEM supplemented with 2% FCS. 
SC-K  a molecules were purified by affinity chromatography on pro- 
tein A-Sepharose coupled with the SFI-I.I.1  mAb. Before use, 
SC-K  a preparations were ultracentrifuged for 1 h at 200,000 g to 
remove any aggregate. 
SC-K  a molecules were loaded with the antigenic peptide and 
dimerized using the SFI-I.I.1 mAb. In some experiments, dimers 
were purified by high-performance gel filtration on Superose 6 HR 
(Pharmacia LKB Biotechnology, Inc.) using a flow rate of 0.35 
ml/min of PBS. 
T  Cell Activation.  The T cell hybridoma 9.4, previously (24) 
obtained by fusion between the 58ot-/~-  T cell thymoma (25) 
and the CW3/1.1 CTL clone (26), is specific  for the Cw3 peptide 
presented by H-2K  a. T cells (10  s) were cultured for 24 h in 200 
/zl of RPMI 1640 medium supplemented  with 10% FCS containing 
the indicated Ka-peptide and mAb or were cultured in microtitra- 
tion plates that had been coated with Kd-peptide by overnight in- 
cubation in PBS. Culture supernatants were collected  and their IL-2 
content was assayed  by measuring the effect of serial dilutions on 
CTLL-2 (American Type Culture Collection T1B 214) prolifera- 
tion in presence of [3H]thymidine  (New England Nuclear, Boston, 
MA). In some experiments, T cells were reisolated, washed, and 
allowed to grow for 3 d at 2  x  10S/ml  in fresh RPMI 1640 con- 
taining 10% FCS. Reactivation was assayed  as previously  or in the 
presence of 10  ng/ml PMA  and  250  ng/ml Ca  2+  ionophore 
A23187 (Sigma Chemical Co.). 
Basophil Transfection.  The Vc~-Cct and V/3-C/8 segments of the 
Cw3/1.1 TCR were fused to transmembrane and cytoplasmic  do- 
mains of the ~"  chain by PCR (27). These constructs were cotrans- 
fected into  RBL-2H3 cells by electroporation using the pAG60 
plasmid as marker (28). Transfectants  were selected  in DMEM sup- 
plemented with 10%  FCS and 1 mg/ml G418 (GIBCO BILL, 
Gaithersburg, MD). High expressers were selected  by flow cytom- 
etry using the H57-597 mAb. 2 wk before cell activation, the G418 
was removed  from the culture medium. Cells were labeled for 15 h 
with serotonin binoxalate (1,2-3H(N)), washed, and incubated for 
1 h with dimers of Ka-peptide. Serotonin exocytosis  was measured 
by counting the radioactivity released in the culture medium as 
previously described (29). 
Results 
Single-chain SC-K  d loaded with peptide activates  baso- 
phils transfected with a TCR-~" fusion. We previously showed 
that  single-chain,  soluble  SC-K  d binds  peptide  (16). We 
wanted to  determine if it  could activate  a  cell  bearing  a 
Ka-restricted  TCR. The T cell chosen for this study (Cw3/ 
1.1) was previously obtained by immunizing DBA/2 mice 
with P815 transfected with the HLA-Cw3 gene (30). Cw3/1.1 
is K a restricted and specific for a  10-mer  peptide derived 
from HLA-Cw3 (hereafter referred to as the Cw3 peptide). 
Its TCR had been cloned and sequenced  (31). 
To test whether the single-chain SC-K  a was biologically 
active, the ot and/3 chains of the Cw3/1.1 TCR were fused 
to the ~'chain of the CD3 complex, and the two fusion genes 
were transfected into the basophilic cell line RBL-2H3 (29). 
Transfected cells expressing high levels of the chimeric TCR 
were selected by flow cytometry  using the anti-C~ H57 mAb. 
Cell activation was measured by incubating the basophilic 
transfectants with SC-K  d and SF1-1.1.1 (an  anti-K  d mAb 
recognizing a single epitope in the c~3 domain) and quan- 
titating serotonin exocytosis. 
As shown in Fig. 1, a specific activation was observed with 
SC-K  d loaded with Cw3, but not with unloaded SC-K  d or 
with SC-K  a loaded with an unrelated peptide (PbCS). In the 
absence of SF1-1.1.1, no cell activation was observed.  This 
indicates that the single-chain SC-K  a interacts with its cog- 
nate TCR in a peptide-specific  manner and transduces an ac- 
tivation signal. 
Single-chain  SC-K a Loaded with Peptide Activates a  T  Cell 
Hybridoma.  To test for the ability of the single-chain SC-K  a 
to act as an antigen-presenting molecule to a T cell, purified 
SC-K  d was  charged with Cw3,  coated onto a  microtiter 
plate, and tested for the ability to stimulate the 9.4 T  cell 
hybridoma. This T cell hybridoma was previously obtained 
by fusing the Cw3/1.1 T cell clone with the 58  ~-/a- T cell 
hybridoma, which is devoid of endogenous TCR (24). Acti- 
vation of the 9.4 hybridoma results in Ib2 secretion, which 
can be monitored by measuring the capacity of the culture 
supernatant to sustain Ib2-dependent CTLL-2 proliferation. 
As shown in Fig. 2, when SC-K  a was loaded with Cw3 
and coated onto the culture plate,  it activated the 9.4 hy- 
bridoma in a dose-dependent manner. This activation was 
peptide specific, as SC-K  d loaded with an unrelated peptide 
(PbCS)  had no activity. 
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Figure  1.  Basophil  activation  by 
recombinant  SC-Kd-Cw3.  Basophils 
transfected with the TCK-~"  fusion were 
incubated for 1 h with 25 #g of SC-K  d 
loaded  with  the  indicated  peptide and 
dimerized with the SF1-1.1.1 mAb. Ser- 
otonin exocytosis was measured in the cul- 
ture supematant. Results are expressed as 
(experimental  -  spontaneous  serotonin 
release)/(total  -  spontaneous  serotonin 
release)  x  100. 
To Activate  T  Cells,  SC-K  d Must Be at Least Dimeric.  In 
the  experiment  shown  in  Fig.  2,  recombinant  SC-K d was 
coated  onto  the  plate,  thereby  mimicking  the  antigen- 
presenting cell surface. The availability  of soluble monomeric 
MHC molecules allowed us to test for the requirement for 
multivalency for MHC molecules to trigger a T hybridoma 
cell. 
Dimers of SC-K a loaded with Cw3 were prepared by in- 
cubating the MHC-peptide complexes with the half-stoichio- 
metric amount of the SF1-1.1.1 mAb specific for a single epi- 
tope located in the c~3 domain of K a (17). This preparation 
was added to the T cell, and activation was measured by IL-2 
secretion. As shown in Fig. 3, a dose-dependent stimulation 
was observed. Note that stimulating the 9.4 T cell hybridoma 
with dimeric SC-K a is more efficient than stimulating with 
coated monomers  of SC-K d,  as  higher  secretion  of IL-2 is 
observed at lower doses of SC-K d (compare Figs.  2 and 3). 
When  a higher  multivalency  was induced  by adding  SC- 
Ka-Cw3,  SF1-1.1.1,  and an anti-mouse Ig antibody, T  cell 
activation was observed at even lower concentrations of SC- 
K d (Fig.  4,  line  6). 
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Figure  2.  Activation  of the  9.4  hybridoma  by  recombinant  SC-K  a 
coated on the plate.  SC-K  d was loaded with either  the Cw3 peptide or 
with  the  unrelated  peptide  PbCS.  The  indicated  quantities  of loaded 
SC-K  d were coated on the plate, and 10  s T cells were added. After  24 h 
at 37~  IL-2 secretion  in the supernatant was measured by its capacity 
to sustain the proliferation of the IL-2-dependent  CTLb2. Results are ex- 
pressed as cpm of [3H]thymidine incorporation  by CTLL-2. 
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Figure  3.  Activation of the 9.4 hybridoma by dimers of SC-Kd-Cw3. 
Purified SC-K  a was loaded with Cw3 and dimerized using the SF1-1.1.1 
mAb. This mixture was incubated  at the indicated concentrations  with 
10  s T  calls. After 24 h, culture  supematants  were harvested and T  cell 
response (II,2 secretion) was measured as described in the legend of Fig. 2. 
T  cell activation was peptide specific,  as dimers made of 
SC-K a molecules charged with unrelated peptides (PbCS or 
NP) did not stimulate the T cells (Fig. 4, lines 4 and 5). No 
stimulation was observed when the Kd-specific antibody was 
omitted (Fig. 4, line 3), when it was replaced by the 20-8-4S 
antibody (line  7) recognizing  an epitope in the al-c~2  do- 
main of K d (19), or when an unrelated antibody of the same 
isotype was used (F23.1  in line 8).  Furthermore,  when  an 
excess of the anti-o4-o~2 (20-8-4S) antibody was used in ad- 
dition to the anti-ol3 (SF1-LI.1) antibody, T cell stimulation 
was lost,  whereas  an excess of the unrelated antibody had 
no  effect  (Fig.  4,  lines 9 and 10). 
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Figure  4.  Activation of T cell hybridoma by SC-K'L-Cw3 requires di- 
merization through the SF1-1.1.1 mAb. SC-K  a (0.3 #g) loaded with the 
indicated peptide was incubated with the indicated antibodies or antibody 
fragments.  These mixtures were then incubated with 10  s T cells, and T 
cell activation was measured as described in the legend of Fig. 2. In line 
6, complex aggregates of Ka-Cw3 were obtained using the SF1-1.1.1 mAb 
and an anti-mouse Ig antibody. In lines 9 and 10, the 20-8-4S mAb (anti- 
o~1-~2) and the F23.1 (unrelated mAb of same isotype)  were in a 10-fold 
molar excess over the SF1-1.1.1 mAb. 
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ization is required  for activation of T  call hybridoma,  SC- 
Kd-Cw3  complexes  were  incubated  with  either  Fab  or 
F(ab')z fragments prepared from the SFI-I.I.1 mAb and were 
used to activate the 9.4 hybridoma. As shown in Fig. 4 (lines 
11 and 12), while Fab fragments had no effect, F(ab')2 were 
as efficient as native Ig in stimulating the T cell hybridoma. 
Activation of the T cell hybridoma could be due to high- 
order aggregates rather than to truly bivalent complexes. To 
prove that dimers were active, we purified material consisting 
of one mAb molecule and two SC-Ka-Cw3 complexes by 
high-performance  gel filtration.  As shown in Fig.  5,  such 
purified dimers  running  with  an apparent  molecular mass 
of 250 kD could activate the 9.4 hybridoma  cell line. 
In summary,  in this  system, monomers  of MHC mole- 
cules do not activate T  ceils. Dimers and higher multimers 
give excellent responses. This activation is blocked by an an- 
tibody recognizing the apical portion (od-ot2) of the MHC 
molecule. 
Dimerization of MHC Molecules Is Required  for Signal Tram- 
duction, Not for Binding.  Initial measurements indicate that 
TCR affinity for its ligand  covers a wide range  of values, 
with KD from 10 -4 tO  10 -7 M  (32-35).  As the concentra- 
tion  of SC-K  d used in  our  assay  is  "d0 -7 M,  one could 
argue that the anti-K d antibody is required to stimulate the 
T cell hybridoma because dimerization increases the apparent 
avidity of the complex for the TCR. Accordingly, the anti- 
body would be required  for binding,  not for triggering. 
To rule out this interpretation,  we designed the following 
experiment.  We took advantage of the slow off-rate of the 
SFI-I.I.1  mAb.  As a consequence of this off-rate, Ka-pep - 
tide complexes dissociate very slowly once they are bound 
to this mAb (16). SC-K  d molecules were loaded with either 
the Cw3 peptide or the unrelated (nonstimulating) PbCS pep- 
tide. While keeping the concentration of SC-Ka-Cw3 con- 
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Figure  5.  Purified dimers  of SC-Ka-Cw3 activate the 9.4 T  cell hy- 
bridoma.  SC-K  a (0.4 mg) was loaded with the Cw3 peptide and incubated 
with SFI-I.I.1 mAb (0.6 rag) for 1 h. This mixture (425/zl) was separated 
by high-performance  gel filtration on a Superose 6 Hlq, column using al- 
bumin (66 kD), aldolase (158 kD), catalase (232 kD), and ferritin (440 
kD)  as  size  markers.  Fractions  containing  SC-K  d were  identified  by 
ELISA. 50/zl of each fraction was incubated  with 105 T hybridoma cells. 
T  cell activation  was measured  as described  in the legend of Fig.  2. 
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stant,  increasing  concentrations  of SC-Kd-PbCS  and SF1- 
1.1.1 mAb were added to the 9.4 hybridoma cells.  In one 
case,  the SC-Kd-peptide complexes were first  mixed with 
the SF1-1.1.1 mAb, and these preformed dimers were then 
added  to  the  T  hybridoma  cells.  In  the  other  case,  SC- 
Ka-peptide complexes were first incubated with  the T  hy- 
bridoma cells, and the SF1-1.1.1 mAb was added afterward. 
As  shown  in  Fig.  6,  when  the  SC-Kd-peptide  dimers 
were preformed (open squares), increasing the concentration 
of SC-Kd-PbCS led to a progressive loss of T cell activation. 
This probably reflected the formation of a decreasing number 
of dimers presenting two Cw3 peptides. In contrast, when 
the two SC-Kd-peptide complexes were first added to the 
hybridoma cells (closed squares), even a 30-fold excess of SC- 
Ka-PbCS over SC-Kd-Cw3 had no negative effect on T cell 
activation.  This indicates  that,  in the absence of SF1-1.1.1, 
monomers  of SC-Ka-Cw3 complexes interact  with  the T 
cell hybridoma cell. 
Activation ofT Cell Hybridoma by MHC-Peptide  Complexes 
Is Followed by a State of Unresponsiveness.  Antigen recogni- 
tion can, under certain conditions, lead to functional inacti- 
vation. In preliminary experiments, T hybridoma cells were 
activated with P815 cells transfected with the HLA-Cw3 gene, 
reisolated, and retested for activation. As already reported for 
other T hybridomas (12), previously activated T cells became 
unresponsive (Abastado, J.-P.,  unpublished  observations). 
To test whether TCR engagement by purified MHC-pep- 
tide dimers  could mimic  this phenomenon,  we performed 
the same experiments with SC-K  a loaded with Cw3. T hy- 
bridoma cells were activated for 24 h using increasing  concen- 
trations of dimers of SC-Ka-Cw3. Cells were then washed, 
cultivated  for 3 d, and retested for activation  by SC-Kd-Cw3. 
As shown in Fig.  7, increasing the concentration of SC-K  a- 
Cw3 used for the first stimulation gradually reduced the re- 
sponse to a second stimulation.  T cell activation by concen- 
trations of SC-Kd-Cw3 above 500 nM induced a state of un- 
responsiveness  in  which  cells  were  refractory  to  further 
activation. 
To assay the specificity of this induction of unresponsive- 
ness,  cells  were incubated with  SC-K  d loaded with  either 
Cw3 or an unrelated peptide (PbCS). After reisolation as de- 
scribed above, T cell response was compared with the response 
of untreated  ceils  (Fig.  8).  Whereas  cells  activated by SC- 
Kd-Cw3 yielded only 3% of the primary response, cells in- 
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Figure  6.  SC-K  d dimerization is re- 
quired  for  T  cell stimulation,  not  for 
binding.  A  mixture  of SC-K  d loaded 
with Cw3 and SC-K  d loaded with PbCS 
at the indicated ratio was incubated with 
SF1-1.1.1 for 2 h and then with the 9.4 
ceils (open squares).  Alternatively, the mix- 
ture was incubated first with the 9.4 cells 
(3 h),  and then the SFI-I.I.1 mAb was 
added (closed squares).  T cell activation was 
measured as described in the legend of Fig. 
2. Only when the dimers were preformed 
was SC-Kd-PbCS  inhibitory. 1~  2~  300  4~ 
E 
) 
2- 
= 
Concentration of SC-Kd/Cw3 
used for the 2d stimulation (nM) 
Figure 7.  Upon activation by SC-Kd-Cw3, T cell hybridoma become 
refractory  to subsequent stimulation. T cells (5  x  l@/ml) were incubated 
for 24 h with dimers of SC-Kd-Cw3 at the following concentrations: 
2,000 nM (-1-),  1,000 nM (-O-), 500 nM (~),  250 nM (--t~), 
and 0 nM (~).  Cells were then reisolated, grown in complete medium 
for 3 d, and retested for activation by dimers of SC-Kd-Cw3 at the con- 
centration indicated on the x-axis of the figure. T cell activation was mea- 
sured as described in the legend of Fig. 2. 
cubated with SC-Ka-PbCS or PBS gave a response identical 
to the primary response  (Fig.  8). 
Unresponsiveness Does Not Result from Selection of  Preexisting 
Cell Variants.  For T  cell hybridomas, TCR occupancy can 
result in reduced cell proliferation (36) and activation-driven 
cell death (37). The above described unresponsiveness could 
therefore result from selection of previously existing response 
variants unable to respond to antigen.  To test  out this hy- 
pothesis, we measured cell viability by trypan blue exclusion 
and apoptosis induction by propidium  iodide staining  and 
flow cytometry (38). No significant difference could be de- 
tected between cells incubated with dimers of SC-Ka-Cw3 
or dimers of SC-Ka-PbCS (data not shown).  We also mea- 
sured the ability of 9.4 cells to form colonies at limiting dilu- 
tion in microtiter plates coated either with dimers  of SC- 
Kd-Cw3  or  with  dimers  of SC-Ka-PbCS.  Although  cell 
colonies grew with a slight delay in wells coated with the 
antigenic complex (SC-Kd-Cw3),  plating efficiencies were 
similar under both conditions  (49  and 59%,  respectively). 
Finally, we reisolated T  cells at different time points  after 
the first antigenic stimulation so that we could control cell 
expansion.  Even under conditions where no cell expansion 
was observed, T  cells that had been previously exposed to 
dimers  of SC-Kd-Cw3  gave a reduced IL-2 secretion (Fig. 
9).  Taken  together,  these  observations  indicate  that  SC- 
Kd-Cw3  dimers do not induce massive cell death and that 
unresponsiveness does not result from selection of preexisting 
unresponsive cells. 
Unresponsiveness Induced by SC-Ka-Cw3  Does Not Result 
from Reduced TCR Expression but from Defective Signal Trans- 
duction.  Unresponsiveness  induced  by SC-Kd-Cw3  could 
result from TCR down-modulation. Cells were treated with 
dimers of SC-K  a loaded with Cw3 or an unrelated peptide 
(PbCS) and were reisolated as described above. TCR expres- 
sion was measured by flow cytometry on reisolated popula- 
tions.  As shown in Fig.  10,  no difference was  observed in 
cell surface expression of the TCR. Untreated cells, cells in- 
cubated  with  SC-Kd-PbCS,  and  cells incubated  with  PBS 
were indistinguishable  (not  shown). 
The same T cell populations were compared for activation 
by dimers  of SC-Ka-Cw3  or a  combination  of PMA  and 
calcium ionophore A23187.  These pharmacological agents 
are known to directly activate protein kinase C (PKC), which 
is involved in T cell activation. As shown in Fig. 8, cells treated 
with  SC-Kd-Cw3  (activated)  were  refractory to  a  second 
stimulation by SC-Ka-Cw3 but gave the same response to 
PMA  and calcium ionophore as untreated cells or cells in- 
cubated previously with SC-Ka-PbCS (control). This indi- 
cates that T cell response could be restored by direct stimula- 
tion of the  PKC. 
c  1 
o 
c 
o 
Control  Activated 
Figure 8.  Induction of unresponsiveness is peptide specific  and is due 
to deficient signal transduction. T cells (105) were incubated with 20/,g 
of SC-K  a loaded with either Cw3 (activated)  or PbCS (control) for 24 h 
in 200 #1 of medium. Cells were then reisolated,  grown in complete  medium 
for 3 d, and retested for activation  by 4/zg SC-K  d loaded with Cw3 (closed 
bars) or by PMA and ionophore A23187 (open bars). T cell activation was 
measured as described in the legend of Fig. 2. Results are expressed as 
percentage of the primary response. 
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Figure 9.  Induction of unresponsiveness  does not require cell amplifica- 
tion. T cells (10  s) were incubated for 24 h with 10 ~g of SC-Ka-Cw3 
(closed bars) or SC-Kd-PbeS (open bars). Cells were then reisolated, in- 
cubated in fresh  culture  medium for the indicated  period of time, and retested 
for activation  by I #g of SC-Ka-Cw3. Secondary  T cell response was mea- 
sured as described in the legend of Fig. 2. 8 
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Figure  10.  Induction of unresponsiveness  does not result from reduced 
TCK expression. T calls (105) were incubated with 20 #g of SC-Kd loaded 
with Cw3 (activated) or PbCS (control) for 24 h in 200 #1 of culture 
medium. Cells were then reisolated, grown in complete medium for 3 d, 
and tested for TCR expression by flow cytometry using the anti-C3 
H57-597 mAb. 
Discussion 
In a previous study, we demonstrated that SC-K  d can bind 
antigenic peptides with the same specificity as the native K d 
molecule (17).  Here we show that  this recombinant  mole- 
cule is fully functional and can act as an antigen-presenting 
molecule to stimulate  a T  cell hybridoma and to induce a 
state of unresponsiveness.  Monovalent SC-K  d molecules show 
no activity, but dimerization is sufficient to make them active. 
The first experimental system used to prove the function- 
ality of the SC-K  a molecule is a basophil expressing a chi- 
meric TCR composed of the extracellular  domains  of the 
c~ and 3 chains fused to the transmembrane and intracellular 
domains of the ~" chain of the CD3.  This system, developed 
by Engel et al.  (29), was chosen because it is very sensitive 
and can detect low-affinity interactions.  The peptide specificity 
of the basophil activation and the fact that TCR interaction 
occurs with  the apical portion of the MHC molecule sug- 
gest that  the observed MHC-peptide  interaction  with the 
chimeric TCR is similar to the physiological interaction be- 
tween a native MHC molecule expressed on an APC and 
the native TCR expressed on a T  cell. 
To further prove the functionality of our recombinant MHC 
molecule in a less artificial system, SC-Kd-peptide was used 
to activate a T  cell hybridoma.  Again,  a specific activation 
was obtained when SC-K  a was coated on a plate or when 
it was dimerized using an anti-or3  mAb or F(ab')2 fragments 
of this mAb. The latter observation shows that the Fc region 
of the cross-linking mAb does not play any role in the activa- 
tion process. Monovalent SC-Ka-peptide,  even in the pres- 
ence of Fab fragments of the anti-or3  mAb, failed to induce 
ILo2 secretion, although  we cannot rule out the possibility 
that they nevertheless generated some second messenger signal. 
Activation by dimers could be blocked by an anti-od-c~2 mAb, 
again supporting a role for this portion of the MHC mole- 
cule in  the interaction  with  the TCR. 
Another soluble recombinant MHC molecule had been pre- 
viously used to activate T  cells (39, 40). However, the min- 
imal level of muhivalency required for activation had not been 
addressed. Here we show that dimerization is sufficient but 
that a higher multivalency level makes activation more effcient. 
For many cell surface receptors, dimerization is sufficient to 
signal cellular responses.  This has been extensively studied 
in the case of the epidermal growth factor receptor,  the human 
growth hormone receptor, and the high-affinity receptor for 
IgE (Fc~RI) (for review see reference 41). Comparison with 
the latter system may be particularly relevant to the present 
study, as the Fc receptor's 3' chain is related to the ~" chain 
of CD3 complex of the TCR, and signal transduction mech- 
anisms  are  likely to be similar in the two systems. 
The level of multivalency required for T  cell activation is 
a highly debated question. Some authors (42-45) argue that 
dimers  are insufficient  for effective intracellular  signaling, 
whereas others (46-49) claim that anti-TCR mAb Fab frag- 
ments can trigger T cells. In the present study, we find that 
dimers of MHC-peptide complexes are fully functional, even 
if higher-order aggregates are more efficient than dimers. One 
explanation for this finding could be that our MHC mole- 
cule preparations are contaminated with traces of aggregates. 
This appears unlikely, as (a) SC-K  a preparations were ultra- 
centrifuged before use;  (b) in  the  absence of cross-linking 
antibody,  SC-Kd-Cw3  complexes fail  to  activate basophil 
transfectants,  a  system in  which  dimers  are known  to be 
sufficient (41); and (c) dimers purified by high-performance 
gel filtration could activate T  hybridoma cells.  While each 
T  cell may have different requirements,  depending,  for ex- 
ample,  on the strength  of the interaction  of the TCR for 
its ligand,  an important  difference in our study is the type 
of stimulus used to trigger  the T  cell.  H. Dintzis  and co- 
workers (42-45) used a system in which the T  cell response 
was not MHC restricted.  Other  studies used an anti-TCR 
mAb. We are using purified MHC-peptide complexes, a more 
physiological ligand. In general, much of what has been learned 
about T  cell activation  stems from studies in which the T 
cell stimulus was not its natural  ligand.  As shown in two 
recent studies (50, 51), a TCK can interpret  subtle changes 
in its ligand, resulting in different tyrosine phosphorylation 
patterns and different signal transduction. Therefore, it might 
be of interest to reevaluate with recombinant  MHC mole- 
cules some of the conclusions drawn from these previous ex- 
periments. 
Why is multivalency required? Several explanations have 
been put forward (34, 39). The first states that multivalency 
is required for binding,  as it enhances the apparent  avidity 
of the MHC-peptide interaction with the TCK. The second 
proposes that muhivalency is required for the stimulation it- 
self.  The  experiment  shown  in  Fig.  6  clearly  shows  that 
monomers of Ka-Cw3 bind to the Cw3-specific T  cell hy- 
bridoma.  This conclusion stems from the observation that 
when SC-Ka-Cw3 and SC-Ka-PbCS monomers are first in- 
cubated with the T cells and SF1-1.1.1 mAb is added subse- 
quently,  T  cells respond by secreting IL-2. Even a 30-fold 
excess of SC-Kd-PbCS does not block this response. To ex- 
plain this, we propose that T cells concentrate SC-Kd-Cw3 
monomers by specifically binding them. Therefore, the con- 
centration  of SC-Kd-Cw3  on  the  T  cell surface is always 
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which is diluted into the medium. Once an mAb molecule 
has bound a SC-Kd-Cw3 complex, it is more likely to bind 
another SC-Kd-Cw3 rather than a SC-Kd-PbCS.  Addition 
of SF1-1.1.1 therefore dimerizes the TCR and triggers signal 
transduction. SC-Kd-Cw3 binding alone (in the absence of 
SF1-1.1.1 addition), however, is not sufficient to trigger the 
T cell. One possible  (but not exclusive) explanation is that 
the interaction of SC-Ka-Cw3 with the TCR does not last 
long enough. By studying the kinetics of reaction between 
an alloreactive TCR and an MHC class I-peptide complex, 
two groups, using different approaches, have come to a similar 
conclusion, namely that the dissociation occurs at a rate that 
is too high (with a half-life for the complex of 27 s) to trigger 
the TCR (34,  35). Antibody addition could be required to 
decrease the effective off-rate. Alternatively, TCR dimeriza- 
tion could be needed for signal transduction. 
Our study emphasizes the importance of TCIK aggrega- 
tion in T  cell activation. Numerous in vitro studies using 
anti-TCR antibodies as the T cell stimulus indicate that TCR 
cross-linking is necessary for T cell triggering (52).  It is not 
clear, however, if and how TCR aggregation occurs in more 
physiological circumstances, in particular when the stimulus 
is a class I MHC-peptide complex expressed at the surface 
of an APC. The fact that thousands of different peptides are 
presented by the same APC (53) seems to preclude the for- 
mation of extensive and stable patches of cross-linked class 
I MHC-peptide complexes. One crucial problem with mul- 
timeric MHC molecules is the question of whether all mole- 
cules in the multimer present the same peptide: If MHC mol- 
ecules are already multimeric before the interaction with the 
TCR, the probability that all MHC molecules in the mul- 
timer are charged with the same peptide decreases rapidly 
with the size of the complex. The valence of MHC class I 
molecules expressed at the cell surface has been the subject 
of many investigations and debates.  MHC class II molecules 
crystallize as dimers. For class I, it has been suggested that 
they are expressed at the cell surface as tetramers (54). How- 
ever, these data were later reinterpreted (55).  On the other 
hand, if monomers of MHC-peptide interact with monomers 
of TC1K, what drives the aggregation of these complexes? 
T  cell triggering has been shown to be a multistep process 
(56). Our results are compatible with a model in which MHC 
molecules interact with their cognate TCR as monomers. 
This interaction then drives the aggregation of the MHC-pep- 
tide-TCR complexes. An alternative hypothesis, which does 
not involve TCR aggregation, is that TCR engagement by 
MHC-peptide complexes induces a conformational change 
in TCR, which in turn transmits the signal inside the cell 
(57). This is not easily compatible with our data, unless TCR 
dimerization induces a conformational change in the CD3 
complex. 
Tolerance induction and maintenance are, in part, the results 
of donal deletion of self-reactive cells in the thymus. Mature 
T cells can also be rendered anergic in the periphery by en- 
countering antigen on nonprofessional APC. Here we show 
that purified dimers of MHC-peptide complexes induce a 
state in which the T  hybridoma cell becomes unresponsive 
to a subsequent antigenic stimulation. This result confirms 
and extends previous observations made about transformed 
or normal T  cells using either APC or anti-TCR mAb as 
stimuli (12,  58).  This unresponsiveness is peptide specific, 
since SC-K  a loaded with an irrelevant peptide has no effect. 
It does not result from reduced TCR expression (Fig.  10), 
as has been previously described (59). It is unlikely to be due 
to TCR blockade (60) by residual MHC-peptide complexes, 
as hyporesponsiveness is assayed after extensive T cell washing 
and 2 d after the first stimulus, a period of time during which 
T  cells proliferate widely. Signal transduction through the 
TCR induces tyrosine kinases and phospholipase C'yl, which 
in turn leads to a rise in intracellular calcium and activation 
of PKC. PKC activation triggers a series ofintracellular events, 
including AP-1  mobilization, which transactivates the IL-2 
promoter. Here we showed that unresponsive T hybridoma 
cells have nevertheless conserved their capacity to produce 
II_-2, as IL-2 secretion can be restored when the cells are stimu- 
lated with phorbol ester and calcium ionophore, which are 
known to activate PKC directly. This suggests that unrespon- 
siveness is due to defective signaling through the TCR and 
that this defect can be bypassed by directly activating PKC. 
The induction of unresponsiveness by soluble recombinant 
MHC class I, as observed in this study, may help to evaluate 
the role of soluble MHC class I molecules in the induction 
of tolerance. Soluble MHC class I molecules circulate in the 
blood (61) as a result of shedding (62).  Nonclassical class Ib 
molecules such as Qa-2 (63), Qb-1 (64),  or Q10 (65) are ac- 
tively secreted. The role of these soluble MHC molecules 
is still a matter of speculation. In transgenic mice expressing 
soluble forms of classical MHC class I molecules, some T 
cells were tolerized and others were not (66, 67). Our finding 
that monomers show no activity but that multimers induce 
T  cell triggering followed by a state of unresponsiveness is 
consistent with a biological role for soluble MHC molecules 
produced by shedding. 
The soluble, single-chain K d molecule described herein is 
fully functional when presented as dimers.  Aggregates of 
dimers (as shown in Fig. 4) were even more efficient than 
dimers, suggesting that dimers, shown here to be necessary 
and sufficient for activation of hybridomas, may not be op- 
timal. Reconstitution experiments as described in this study 
may prove useful to dissecting and evaluating,  in  a well- 
controlled experimental system, the requirements for T cell 
activation and induction of anergy. This could be of partic- 
ular interest for finding new therapeutic approaches involving 
the specific modulation of immune responses. 
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